GNCA - ジェノシア・バイオサイエンシズ (Genocea Biosciences Inc.)


   Iovance up 28% premarket on positive TIL data  2019-05-16
Iovance Biotherapeutics (NASDAQ: IOVA ) is up 28% premarket on light volume in reaction to new interim data from clinical trials evaluating its tumor-infiltrating lymphocyte (TIL) candidates. The data will be presented at ASCO in Chicago. More news on: Iovance Biotherapeutics…
   Funds And Fundamentals Breaking Down: What Are Your Best Alternatives For 2019?  2019-01-04
Every decision is a kind of prediction… and every prediction, crucially, involves thinking about two distinct things: What you know and what you don't. - B. Christian & T. Griffiths, Algorithms to Live By How have stock fundamentals broken down? Were you sold a wonderful ...